Introduction Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm marked by the presence of the Philadelphia chromosome and uncontrolled granulocyte production. While autoimmune hemolytic a

DataCite Commons2024-11-27 更新40

The HDAC inhibitor CI-994 acts as a molecular memory aid by facilitating synaptic and intra-cellular communication after learning [RNA-seq]. The HDAC inhibitor CI-994 acts as a molecular memory aid by facilitating synaptic and intra-cellular communication after learning [RNA-seq]

记忆分子机制

HDAC抑制剂作用机制

Long-term memory formation relies on synaptic plasticity, activity-dependent transcription and epigenetic modifications. Multiple studies have shown that HDAC inhibitor (HDACi) treatments can enhance

NIAID Data Ecosystem20

table2_miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.xlsx

慢性髓性白血病

miRNome

Chronic myeloid leukemia (CML) is a myeloid stem cell neoplasm characterized by an expansion of myeloid progenitor cells and the presence of BCR-ABL1 oncoprotein. Since the introduction of specific BC

NIAID Data Ecosystem40

Supplementary Material for: Regulation of miR-126 and miR-122 Expression and Response of Imatinib Treatment on Its Expression in Chronic Myeloid Leukemia Patients

慢性髓性白血病

miRNA表达

Background: MicroRNAs (miRNAs) have been observed to exhibit altered expression patterns in chronic myeloid leukemia (CML). Therefore, this study was aimed to evaluate the clinical importance of miR-1

NIAID Data Ecosystem40

Additional file 2 of Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia

资源简介：

相关数据集